knowledge -WSS

knowledge

author：Wikipedia 2025-08-12 08:29:57 - browse：291

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： What AAP's gender

WSS

Psilocybin's anti

Radiation, mainstay of cancer treatment, begins a fade

What AAP's gender

NYU Langone launches private ChatGPT for its health care data

Readout Newsletter: XBI biotech index, Akero Therapeutics

Diversity in medical illustrations gets boost from Chidiebere Ibe

leisure time

knowledge

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: New research from Sanofi, Regeneron, etc.

The cancer drug shortage isn’t new — and neither are the solutions

NYU Langone launches private ChatGPT for its health care data

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How a symptom of dementia informs our understanding of creativity

How one medical school became remarkably diverse

Why Sanofi got shellacked over its spinoff

Affirmative action in medical school literally saved lives

FDA has safety concerns on CRISPR

knowledge

Paying for Covid pills will soon shift to insurers

Neuroscience startup Neumora files for IPO

AstraZeneca bets AAV gene therapy will still deliver the goods

What do new weight loss drugs mean for bariatric surgery?

Telehealth options flood the market as retailers push virtual care

Paying for Covid pills will soon shift to insurers

leisure time

focus

focus

focus